Gene · 3487
Papers2,963
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 2,963
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Revolutionizing drug development: harnessing the potential of organ-on-chip technology for disease modeling and drug discovery. | Front Pharmacol | 2023 | 37180709 | PubTator, text mining | PubMed |
| PAPP-A-Specific IGFBP-4 Proteolysis in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. | Int J Mol Sci | 2023 | 37176126 | PubTator, text mining | PubMed |
| Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. | Cells | 2023 | 37174697 | PubTator, text mining | PubMed |
| Angiogenic signaling pathways and anti-angiogenic therapy for cancer. | Signal Transduct Target Ther | 2023 | 37169756 | PubTator, text mining | PubMed |
| Insulin-like growth factor binding Protein-4: A novel indicator of pulmonary arterial hypertension severity and survival. | Pulm Circ | 2023 | 37152104 | PubTator, text mining | PubMed |
| Biochemical Screening for Fetal Trisomy 21: Pathophysiology of Maternal Serum Markers and Involvement of the Placenta. | Int J Mol Sci | 2023 | 37108840 | PubTator, text mining | PubMed |
| Long non-coding RNAs as critical regulators and novel targets in cervical cancer: current status and future perspectives. | Apoptosis | 2023 | 37095313 | PubTator, text mining | PubMed |
| Expression characteristics and their functional role of IGFBP gene family in pan-cancer. | BMC Cancer | 2023 | 37088808 | PubTator, text mining | PubMed |
| Development of cell-laden multimodular Lego-like customizable endometrial tissue assembly for successful tissue regeneration. | Biomater Res | 2023 | 37085887 | PubTator, text mining | PubMed |
| Circulating biomarkers associated with placental dysfunction and their utility for predicting fetal growth restriction. | Clin Sci (Lond) | 2023 | 37075762 | PubTator, text mining | PubMed |
| Wnt Signaling Inhibitors and Their Promising Role in Tumor Treatment. | Int J Mol Sci | 2023 | 37047705 | PubTator, text mining | PubMed |
| Increased SEC23A Expression Correlates with Poor Prognosis and Immune Infiltration in Stomach Adenocarcinoma. | Cancers (Basel) | 2023 | 37046730 | PubTator, text mining | PubMed |
Integrated analysis of methylation profiles and transcriptome of Marek's disease virus-infected chicken spleens reveal hypomethylation of CD4 and HMGB1 genes might promote Marek's disease tumorigenesis. | Poult Sci | 2023 | 37043960 | PubTator, text mining | PubMed |
| Single-Cell RNA Sequencing Reveals Unique Alterations in the Immune Panorama and Treg Subpopulations in Mice during the Late Stages of Echinococcus granulosus Infection. | Infect Immun | 2023 | 37039643 | PubTator, text mining | PubMed |
| Cord blood transforming growth factor-β-induced as predictive biomarker of retinopathy of prematurity in preterm infants. | Graefes Arch Clin Exp Ophthalmol | 2023 | 37022494 | PubTator, text mining | PubMed |
| Effects of prenatal pesticide exposure on the fetal brain and placenta transcriptomes in a rodent model. | Toxicology | 2023 | 37019170 | PubTator, text mining | PubMed |
| The role of RNA methyltransferase METTL3 in gynecologic cancers: Results and mechanisms. | Front Pharmacol | 2023 | 37007040 | PubTator, text mining | PubMed |
| Expression patterns of eight RNA-modified regulators correlating with immune infiltrates during the progression of osteoarthritis. | Front Immunol | 2023 | 37006267 | PubTator, text mining | PubMed |
| Metabolic reprogramming in cancer: Mechanisms and therapeutics. | MedComm (2020) | 2023 | 36994237 | PubTator, text mining | PubMed |
| Development and Validation of a Prognostic Risk Model Based on Nature Killer Cells for Serous Ovarian Cancer. | J Pers Med | 2023 | 36983585 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3487/papers?page=12